CeriBell (NASDAQ:CBLL) Stock Price Up 9.5% - Still a Buy?

Key Points

• CeriBell's (NASDAQ:CBLL) stock price increased by 9.5%, trading as high as $13.39 before closing at $13.69, although total trading volume was down by 9% from its average.
• Research analysts have differing opinions on CeriBell, with one giving a strong-buy rating and a $19.00 price target, while Weiss Ratings issued a sell rating.
• CeriBell reported earnings of ($0.38) per share, surpassing analyst expectations, with a revenue of $21.20 million during the last quarter.

Shares of CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) shot up 9.5% during trading on Tuesday . The stock traded as high as $13.39 and last traded at $13.69. 256,779 shares traded hands during trading, a decline of 9% from the average session volume of 283,583 shares. The stock had previously closed at $12.50.

Analysts Set New Price Targets

CBLL has been the topic of a number of research analyst reports. BTIG Research assumed coverage on shares of CeriBell in a research note on Tuesday, June 24th. They issued a "buy" rating and a $30.00 target price on the stock. Raymond James Financial began coverage on CeriBell in a research report on Tuesday. They issued a "strong-buy" rating and a $19.00 price target on the stock. Finally, Weiss Ratings reissued a "sell (e+)" rating on shares of CeriBell in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, CeriBell currently has an average rating of "Moderate Buy" and an average target price of $30.50.

CeriBell Stock Performance

The stock has a fifty day moving average price of $11.96 and a 200-day moving average price of $14.90. The company has a current ratio of 13.31, a quick ratio of 12.91 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $496.56 million and a price-to-earnings ratio of -4.53.

CeriBell (NASDAQ:CBLL - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.40) by $0.02. The firm had revenue of $21.20 million during the quarter, compared to analyst estimates of $20.52 million. CeriBell had a negative return on equity of 48.42% and a negative net margin of 63.83%. CeriBell has set its FY 2025 guidance at EPS. As a group, analysts anticipate that CeriBell, Inc. will post -2.46 earnings per share for the current fiscal year.

Insider Activity

In other news, CTO Raymond Woo sold 11,112 shares of the business's stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $12.54, for a total value of $139,344.48. Following the transaction, the chief technology officer directly owned 167,704 shares of the company's stock, valued at $2,103,008.16. The trade was a 6.21% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 20.10% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Yu Fan increased its position in CeriBell by 10.7% in the 2nd quarter. Yu Fan now owns 1,353,166 shares of the company's stock valued at $25,345,000 after acquiring an additional 130,964 shares in the last quarter. Novo Holdings A S grew its stake in shares of CeriBell by 2.3% during the second quarter. Novo Holdings A S now owns 900,000 shares of the company's stock valued at $16,857,000 after purchasing an additional 20,000 shares during the last quarter. TimesSquare Capital Management LLC increased its holdings in shares of CeriBell by 48.5% in the second quarter. TimesSquare Capital Management LLC now owns 796,945 shares of the company's stock valued at $14,927,000 after purchasing an additional 260,116 shares in the last quarter. Federated Hermes Inc. lifted its holdings in CeriBell by 111.3% during the 1st quarter. Federated Hermes Inc. now owns 786,751 shares of the company's stock worth $15,113,000 after buying an additional 414,500 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in CeriBell by 55.4% during the second quarter. Geode Capital Management LLC now owns 447,936 shares of the company's stock valued at $8,391,000 after purchasing an additional 159,698 shares during the period.

About CeriBell

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.